Skip to main content
. 2023 Jun 27;29(10):870–877. doi: 10.1093/oncolo/oyad166

Table 2.

Imaging and pathologic response to IO.

Pre-nephrectomy RECIST 1.1
Systemic disease Primary tumor
Progressive disease 2 (4%) 5 (10%)
Stable disease 15 (29%) 21 (40%)
Partial response 33 (63%) 22 (42%)
Unknown 2 (4%) 4 (8%)
Pathologic outcomes
Baseline
T stage
Pathologic
T stage
T0 0 (0%) 7 (13%)
T1 5 (10%) 8 (15%)
T2 14 (27%) 6 (12%)
T3 19 (37%) 27 (52%)
T4 13 (25%) 4 (8%)
Unknown 1 (2%) 0 (0%)